Strul Hana, Kariv Revital, Leshno Moshe, Halak Aharon, Jakubowicz Markus, Santo Moshe, Umansky Mark, Shirin Haim, Degani Ya'ara, Revivo Miri, Halpern Zamir, Arber Nadir
Department of Gastroenterology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Am J Gastroenterol. 2006 Feb;101(2):255-62. doi: 10.1111/j.1572-0241.2006.00430.x.
The role of screening colonoscopy for colorectal (CR) neoplasia in average-risk population, remains to be determined.
To evaluate the prevalence and anatomic location of CR adenoma and carcinoma and the morbidity of colonoscopy in individuals at average risk for CR cancer (CRC).
A retrospective prevalence study of subjects aged 40-80 yr, with no cancer-related symptoms, personal or family history of CR neoplasia, who underwent a colonoscopy.
Enrolled were 1,177 persons; 183 aged 40-49 yr (young), 917 aged 50-75 yr, and 77 aged 76-80 yr (elderly). The prevalence of overall CR neoplasia, advanced neoplasia, and cancer was 20.9%, 6.3%, and 1.1%, respectively. In the 50-75 age group, the prevalence of overall adenoma, advanced neoplasia, and cancer was 21.3%, 6.7%, and 1.2%, respectively. Of the 206 neoplasia cases, 21-43% harbored proximal neoplasia beyond the reach of sigmoidoscopy, without distal lesions. Among the elderly, the prevalence of overall adenoma, advanced neoplasia, and cancer reached 26.0%, 14.3%, and 2.6%, respectively. In the young group, 9.8% had overall neoplasia, 1.1% had advanced adenoma, and none had CRC. Procedure-related morbidity rate was 0.1%, with no perforations, bleedings, or mortality.
Screening colonoscopy in average-risk subjects demonstrated a considerable prevalence of CR neoplasia and proximal lesions beyond the reach of sigmoidoscopy. The morbidity rate was negligible. Primary screening colonoscopy should be considered in health programs for the average-risk population, beginning at the age of 50 yr. The significantly high rate of advanced and proximal neoplasia in the elderly, encourages the inclusion of healthy subjects aged 76-80 yr in future prospective studies.
在一般风险人群中,筛查结肠镜检查对结直肠(CR)肿瘤的作用仍有待确定。
评估CR腺瘤和癌的患病率、解剖位置以及CR癌(CRC)平均风险个体的结肠镜检查发病率。
对年龄在40 - 80岁、无癌症相关症状、无CR肿瘤个人或家族史且接受了结肠镜检查的受试者进行一项回顾性患病率研究。
共纳入1177人;其中183人年龄在40 - 49岁(年轻组),917人年龄在50 - 75岁,77人年龄在76 - 80岁(老年组)。CR肿瘤、进展期肿瘤和癌症的总体患病率分别为20.9%、6.3%和1.1%。在50 - 75岁年龄组中,腺瘤、进展期肿瘤和癌症的总体患病率分别为21.3%、6.7%和1.2%。在206例肿瘤病例中,21% - 43%存在乙状结肠镜检查范围以外的近端肿瘤,且无远端病变。在老年组中,腺瘤、进展期肿瘤和癌症的总体患病率分别达到26.0%、14.3%和2.6%。在年轻组中,9.8%有总体肿瘤,1.1%有进展性腺瘤,无CRC病例。与操作相关的发病率为0.1%,无穿孔、出血或死亡情况。
对一般风险受试者进行筛查结肠镜检查显示,CR肿瘤和乙状结肠镜检查范围以外的近端病变患病率相当高。发病率可忽略不计。对于一般风险人群的健康计划,应考虑从50岁开始进行初次筛查结肠镜检查。老年人中进展期和近端肿瘤的显著高发病率,促使在未来的前瞻性研究中纳入76 - 80岁的健康受试者。